- Wealth
- ₹1,100 Cr
- Company
- Indoco Remedies
About Suresh Govind Kare
Data last updated:
Suresh Govind Kare is a Director at Indoco Remedies Limited (since 1963), Additional Director at Warren Remedies Private Limited (since 2025) and Director at Spa Holdings Private Limited (since 1998), and holds 2 more current directorships. The companies operate in Pharma and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹1,790 Cr; the largest is Indoco Remedies Limited at ₹1,670 Cr (FY 2025). Earlier, Suresh Govind Kare was a Director at Indoco Healthcare Limited (from 1998) and Director at La Nova Chem (India) Private Limited (from 2006) and 5 more.
Suresh G Kare is #1,673 among India's richest people (2026), with wealth of ₹1,100 Cr.
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Jul 1963 | 1947 | ₹1,670 Cr (FY 2025) | Active | |
| Additional Director | 05 Nov 2025 | 2022 | ₹98.74 Cr (FY 2025) | Active | |
| Director | 01 Jun 1998 | 1987 | ₹12.72 Cr (FY 2025) | Active | |
| Director | 01 Jun 1998 | 1985 | ₹8.49 Cr (FY 2025) | Active | |
| Director | 01 Jun 1998 | 1995 | ₹5.4 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Sep 1998 | 1998 | Amalgamated | ||
| Director | 04 Jul 2006 | 2003 | Amalgamated | ||
| Director | 20 Apr 1999 | 1988 | Amalgamated | ||
| Director | 20 Jan 1983 | 1983 | Amalgamated | ||
| Director | 26 Jun 2012 | 2012 | Strike Off | ||
| Additional Director | 21 Jan 2008 | 2006 | Amalgamated | ||
| Director | 20 Apr 1999 | 1973 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Suresh Govind Kare
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Govind Kare
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Govind Kare
Suresh Govind Kare currently holds 5 directorships: Indoco Remedies Limited (Director, since 02 Jul 1963, revenue ₹1,670 Cr (FY 2025)); Warren Remedies Private Limited (Additional Director, since 05 Nov 2025, revenue ₹98.74 Cr (FY 2025)); Spa Holdings Private Limited (Director, since 01 Jun 1998, revenue ₹12.72 Cr (FY 2025)); Shanteri Investment Private Limited (Director, since 01 Jun 1998, revenue ₹8.49 Cr (FY 2025)); Indoco Capital Markets Limited (Director, since 01 Jun 1998, revenue ₹5.4 Lakh (FY 2025)).
Suresh Govind Kare was first appointed on 02 Jul 1963 as Director at Indoco Remedies Limited. The most recent appointment on record is 05 Nov 2025 at Warren Remedies Private Limited.
The 5 current companies of Suresh Govind Kare that report revenue have a combined latest revenue of ₹1,790 Cr: Indoco Remedies Limited ₹1,670 Cr (FY 2025); Warren Remedies Private Limited ₹98.74 Cr (FY 2025); Spa Holdings Private Limited ₹12.72 Cr (FY 2025); Shanteri Investment Private Limited ₹8.49 Cr (FY 2025); Indoco Capital Markets Limited ₹5.4 Lakh (FY 2025).
Suresh Govind Kare held 7 earlier board appointments: Indoco Healthcare Limited (Director, from 04 Sep 1998); La Nova Chem (India) Private Limited (Director, from 04 Jul 2006); Warren Laboratories Limited (Director, from 20 Apr 1999); Ameya Pharmaceuticals And Chemicals Private Limited (Director, from 20 Jan 1983); Indoco Pharmchem Limited (Director, from 26 Jun 2012); and 2 more.
The current boards of Suresh Govind Kare's companies include Abhijit Yashawant Gore (Indoco Remedies Limited), Aditi Milind Panandikar (Indoco Remedies Limited), Ajay Prasan Mulgaokar (Indoco Remedies Limited), Pramod Ramchandra Ghorpade (Indoco Remedies Limited), Ramanathan Hariharan (Indoco Remedies Limited), Satish Madhav Shenoy (Indoco Remedies Limited), among others.